U.S. House Passes Arrington-Spanberger-Boyle Bill to Increase Negotiation Transparency, Lower Costs of Prescription Drugs
October 29, 2019
October 29, 2019
WASHINGTON, Oct. 29 -- Rep. Jodey Arrington, R-Texas, issued the following news release:
Today, the U.S. House of Representatives voted 403-0 to pass the Public Disclosure of Drug Discounts Act (H.R. 2115) - bipartisan legislation introduced by Congressman Jodey Arrington (TX-19), Congresswoman Abigail Spanberger (VA-7), and Congressman Brendan Boyle (PA-2) to provide greater transparency to the discounts negotiated between insurance companies and drug manufacturers through Pharmace . . .
Today, the U.S. House of Representatives voted 403-0 to pass the Public Disclosure of Drug Discounts Act (H.R. 2115) - bipartisan legislation introduced by Congressman Jodey Arrington (TX-19), Congresswoman Abigail Spanberger (VA-7), and Congressman Brendan Boyle (PA-2) to provide greater transparency to the discounts negotiated between insurance companies and drug manufacturers through Pharmace . . .